A New Pathway for Antibiotic Innovation: Exploring Drug Development for Limited Populations
The Pew Health Group is holding a one-day conference, “A New Pathway for Antibiotic Innovation: Exploring Drug Development for Limited Populations” on Thursday, January 31, 2013 at The Pew Charitable Trusts office located at 901 E Street NW, Washington, D.C.
As multidrug-resistant infections have grown more prevalent, few new antibiotics are reaching the market. This is attributed, in part, to the economic and regulatory challenges associated with their development. Recently, stakeholders have endorsed a novel regulatory pathway to approve these lifesaving drugs for use in limited patient populations—namely those at highest risk and with few or no other options. Leaders representing the drug industry, health care providers, government regulators and payors will come together to advance this concept and explore its feasibility from a business and public health perspective.
If you are unable to attend in person, you may also observe the conference via a live webcast, which you will be able to access on Thursday, Jan. 31.
- Agenda (PDF)
- Speaker Biographies (PDF)
- Background Materials (PDF)
